The market for cannabis-based products is booming, and the Food and Drug Administration (FDA) is struggling to keep up. Booming cannabis market puts pressure on FDA

The market for cannabis-based products is booming, and the Food and Drug Administration (FDA) is struggling to keep up.

Congress legalized the use of hemp-based cannabidiol (CBD) products late last year in the farm bill, sending the agency scrambling to figure out new rules around regulating a unique product that is both a drug and a dietary supplement.

The agency is facing bipartisan pressure from lawmakers to quickly come up with a solution. In the meantime, the CBD industry is operating in a grey area and facing uncertainty about what the next steps will be.

Hemp farmers, distributors and manufacturers saw the farm bill as a major opportunity for the future of CBD. But the FDA’s attempts to assert its authority have instead led to confusion.

MJ Shareholders avatar

MJ Shareholders

MJShareholders.com is the largest dedicated financial network and leading corporate communications firm serving the legal cannabis industry. Our network aims to connect public marijuana companies with these focused cannabis audiences across the US and Canada that are critical for growth: Short and long term cannabis investors Active funding sources Mainstream media Business leaders Cannabis consumers




( ) ( ) ( ) ( ) ( ) ( ) ( ) ( )